Our study found that RLP8 and TTC35 genes were significantly increased in advanced grades of pancreatic tumor tissues compared to the controls, suggesting that these genes are key negative regulators that not only increase aggressiveness in pancreatic cancer cells but also contribute to ferroptosis resistance. The gene discussed is EMC2; the disease is pancreatic neoplasm.